UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT
INVESTMENT COMPANIES
Investment Company Act file number 811-10071
Oppenheimer Emerging Growth Fund
(Exact name of registrant as specified in charter)
6803 South Tucson Way, Centennial, Colorado 80112-3924
(Address of principal executive offices)
(Zip code)
Robert G. Zack, Esq.
OppenheimerFunds, Inc.
Two World Financial Center, New York, New York 10281-1008
- --------------------------------------------------------------------------------
(Name and address of agent for service)
Registrant's telephone number, including area code: (303) 768-3200
--------------
Date of fiscal year end: October 31
Date of reporting period: November 1, 2003 - April 30, 2004
Item 1. Reports to Stockholders.
STATEMENT OF INVESTMENTS April 30, 2004 / Unaudited
MARKET VALUE
SHARES SEE NOTE 1
- -------------------------------------------------------------------------
COMMON STOCKS--102.8%
- -------------------------------------------------------------------------
CONSUMER DISCRETIONARY--14.4%
- -------------------------------------------------------------------------
HOTELS, RESTAURANTS & LEISURE--4.1%
Chicago Pizza &
Brewery, Inc. 1 45,400 $ 600,188
- -------------------------------------------------------------------------
Multimedia
Games, Inc. 1 22,900 510,212
- -------------------------------------------------------------------------
Ruby Tuesday, Inc. 19,000 568,480
- -------------------------------------------------------------------------
Scientific Games
Corp., Cl. A 1 71,100 1,282,644
- -------------------------------------------------------------------------
Shuffle Master, Inc. 1 21,600 707,400
- -------------------------------------------------------------------------
Station Casinos, Inc. 16,000 721,280
-------------
4,390,204
- -------------------------------------------------------------------------
HOUSEHOLD DURABLES--1.5%
Meritage Corp. 1 14,500 983,825
- -------------------------------------------------------------------------
Standard Pacific Corp. 10,900 549,796
-------------
1,533,621
- -------------------------------------------------------------------------
INTERNET & CATALOG RETAIL--1.0%
Coldwater Creek, Inc. 1 21,600 444,744
- -------------------------------------------------------------------------
Priceline.com, Inc. 1 27,200 659,056
-------------
1,103,800
- -------------------------------------------------------------------------
LEISURE EQUIPMENT & PRODUCTS--2.0%
Marvel Enterprises,
Inc. 1 113,900 2,162,961
- -------------------------------------------------------------------------
MEDIA--1.6%
Cumulus Media,
Inc., Cl. A 1 18,500 388,870
- -------------------------------------------------------------------------
Radio One, Inc. 1 24,800 473,184
- -------------------------------------------------------------------------
Radio One, Inc., Cl. D 1 22,700 430,392
- -------------------------------------------------------------------------
TiVo, Inc. 1 64,600 452,846
-------------
1,745,292
- -------------------------------------------------------------------------
SPECIALTY RETAIL--3.5%
American Eagle
Outfitters, Inc. 1 27,200 698,768
- -------------------------------------------------------------------------
Big 5 Sporting Goods
Corp. 1 36,300 900,966
- -------------------------------------------------------------------------
Urban Outfitters, Inc. 1 28,800 1,329,696
- -------------------------------------------------------------------------
West Marine, Inc. 1 27,200 790,976
-------------
3,720,406
MARKET VALUE
SHARES SEE NOTE 1
- -------------------------------------------------------------------------
TEXTILES, APPAREL & LUXURY GOODS--0.7%
Quicksilver, Inc. 1 31,800 $ 687,834
- -------------------------------------------------------------------------
CONSUMER STAPLES--1.8%
- -------------------------------------------------------------------------
FOOD PRODUCTS--1.0%
Sanderson Farms, Inc. 29,600 1,100,528
- -------------------------------------------------------------------------
PERSONAL PRODUCTS--0.8%
NBTY, Inc. 1 22,700 843,532
- -------------------------------------------------------------------------
ENERGY--2.2%
- -------------------------------------------------------------------------
ENERGY EQUIPMENT & SERVICES--0.7%
Maverick Tube Corp. 1 34,500 780,735
- -------------------------------------------------------------------------
OIL & GAS--1.5%
Brigham
Exploration Co. 1 91,800 788,562
- -------------------------------------------------------------------------
Spinnaker
Exploration Co. 1 20,800 741,936
-------------
1,530,498
- -------------------------------------------------------------------------
FINANCIALS--5.3%
- -------------------------------------------------------------------------
CAPITAL MARKETS--0.5%
National Financial
Partners Corp. 18,700 584,375
- -------------------------------------------------------------------------
COMMERCIAL BANKS--1.1%
UCBH Holdings, Inc. 12,000 444,240
- -------------------------------------------------------------------------
Westcorp 16,500 727,650
-------------
1,171,890
- -------------------------------------------------------------------------
DIVERSIFIED FINANCIAL SERVICES--1.5%
CapitalSource, Inc. 1 31,200 657,072
- -------------------------------------------------------------------------
Investors Financial
Services Corp. 15,100 586,937
- -------------------------------------------------------------------------
Raymond James
Financial, Inc. 12,150 305,208
-------------
1,549,217
- -------------------------------------------------------------------------
INSURANCE--0.6%
Bristol West
Holdings, Inc. 1 10,900 223,450
- -------------------------------------------------------------------------
Direct General Corp. 10,300 368,225
-------------
591,675
- -------------------------------------------------------------------------
REAL ESTATE--0.8%
Orleans
Homebuilders, Inc. 1 45,400 821,286
11 | OPPENHEIMER EMERGING GROWTH FUND
STATEMENT OF INVESTMENTS Unaudited / Continued
MARKET VALUE
SHARES SEE NOTE 1
- --------------------------------------------------------------------------------
THRIFTS & MORTGAGE FINANCE--0.8%
Commercial Capital
Bancorp, Inc. 1 50,100 $ 884,766
- --------------------------------------------------------------------------------
HEALTH CARE--25.6%
- --------------------------------------------------------------------------------
BIOTECHNOLOGY--8.1%
Digene Corp. 1 36,900 1,309,950
- --------------------------------------------------------------------------------
Gen-Probe, Inc. 1 35,700 1,190,238
- --------------------------------------------------------------------------------
LifeCell Corp. 1 63,600 572,400
- --------------------------------------------------------------------------------
Martek Biosciences
Corp. 1 31,300 1,987,237
- --------------------------------------------------------------------------------
Medarex, Inc. 1 27,200 259,216
- --------------------------------------------------------------------------------
Pharmacyclics, Inc. 1 64,800 771,120
- --------------------------------------------------------------------------------
QLT
PhotoTherapeutics,
Inc. 1 65,500 1,766,535
- --------------------------------------------------------------------------------
VaxGen, Inc. 1 51,500 780,225
-------------
8,636,921
- --------------------------------------------------------------------------------
HEALTH CARE EQUIPMENT & SUPPLIES--6.2%
BioLase
Technology, Inc. 1 38,700 498,456
- --------------------------------------------------------------------------------
Endocardial
Solutions, Inc. 1 72,600 588,060
- --------------------------------------------------------------------------------
I-Flow Corp. 1 59,000 863,760
- --------------------------------------------------------------------------------
Inamed Corp. 1 16,300 959,092
- --------------------------------------------------------------------------------
Kyphon, Inc. 1 38,800 973,880
- --------------------------------------------------------------------------------
Palomar Medical
Technologies, Inc. 1 88,600 1,394,564
- --------------------------------------------------------------------------------
Possis Medical, Inc. 1 20,000 508,600
- --------------------------------------------------------------------------------
Sonic Innovations, Inc. 1 81,700 747,555
-------------
6,533,967
- --------------------------------------------------------------------------------
HEALTH CARE PROVIDERS & SERVICES--5.3%
Bio-Imaging
Technologies, Inc. 1,2 112,400 574,908
- --------------------------------------------------------------------------------
eResearch
Technology, Inc. 1 61,350 1,931,298
- --------------------------------------------------------------------------------
HealthExtras, Inc. 1 54,500 693,240
- --------------------------------------------------------------------------------
Omnicell, Inc. 1 54,500 751,010
- --------------------------------------------------------------------------------
Symbion, Inc. 1 24,200 394,460
- --------------------------------------------------------------------------------
TLC Vision Corp. 1 50,000 594,000
- --------------------------------------------------------------------------------
Ventiv Health, Inc. 1 46,400 652,848
-------------
5,591,764
MARKET VALUE
SHARES SEE NOTE 1
- --------------------------------------------------------------------------------
PHARMACEUTICALS--6.0%
Able Laboratories, Inc. 1 18,200 $ 350,350
- --------------------------------------------------------------------------------
Angiotech
Pharmaceuticals, Inc. 1 41,400 863,190
- --------------------------------------------------------------------------------
Axcan Pharma, Inc. 1 36,300 621,819
- --------------------------------------------------------------------------------
DOV Pharmaceutical,
Inc. 1,2 44,700 773,757
- --------------------------------------------------------------------------------
First Horizon
Pharmaceutical Corp. 1 54,500 845,295
- --------------------------------------------------------------------------------
Impax
Laboratories, Inc. 1 33,600 699,216
- --------------------------------------------------------------------------------
K-V Pharmaceutical
Co., Cl. A 1 10,100 242,602
- --------------------------------------------------------------------------------
MGI Pharma, Inc. 1 27,400 1,693,868
- --------------------------------------------------------------------------------
Penwest
Pharmaceuticals Co. 1 20,000 318,000
-------------
6,408,097
- --------------------------------------------------------------------------------
INDUSTRIALS--8.9%
- --------------------------------------------------------------------------------
COMMERCIAL SERVICES & SUPPLIES--6.0%
Bennett
Environmental, Inc. 1 32,300 363,698
- --------------------------------------------------------------------------------
Corinthian
Colleges, Inc. 1 81,000 2,480,220
- --------------------------------------------------------------------------------
Gevity HR, Inc. 29,300 645,479
- --------------------------------------------------------------------------------
Intersections, Inc. 1 1,800 44,460
- --------------------------------------------------------------------------------
Sylvan Learning
Systems, Inc. 1 34,000 1,198,500
- --------------------------------------------------------------------------------
Universal Technical
Institute, Inc. 1 35,700 1,588,293
-------------
6,320,650
- --------------------------------------------------------------------------------
MACHINERY--0.5%
Ceradyne, Inc. 1 19,900 567,946
- --------------------------------------------------------------------------------
ROAD & RAIL--1.9%
Landstar System, Inc. 1 18,200 818,272
- --------------------------------------------------------------------------------
Pacer International,
Inc. 1 31,200 586,560
- --------------------------------------------------------------------------------
Yellow Roadway
Corp. 1 18,500 629,925
-------------
2,034,757
12 | OPPENHEIMER EMERGING GROWTH FUND
MARKET VALUE
SHARES SEE NOTE 1
- --------------------------------------------------------------------------------
TRADING COMPANIES & DISTRIBUTORS--0.5%
MSC Industrial
Direct Co., Inc., Cl. A 17,400 $ 498,684
- --------------------------------------------------------------------------------
INFORMATION TECHNOLOGY--44.2%
- --------------------------------------------------------------------------------
COMMUNICATIONS EQUIPMENT--8.5%
ADTRAN, Inc. 52,000 1,274,520
- --------------------------------------------------------------------------------
Airspan Networks, Inc. 1 72,600 387,684
- --------------------------------------------------------------------------------
Arris Group, Inc. 1 92,200 551,356
- --------------------------------------------------------------------------------
Audiocodes Ltd. 1 85,500 801,990
- --------------------------------------------------------------------------------
Ditech
Communications
Corp. 1 72,600 1,043,988
- --------------------------------------------------------------------------------
F5 Networks, Inc. 1 31,600 802,640
- --------------------------------------------------------------------------------
Ixia 1 50,500 450,965
- --------------------------------------------------------------------------------
Performance
Technologies, Inc. 1 101,900 1,323,681
- --------------------------------------------------------------------------------
Powerwave
Technologies, Inc. 1 53,700 363,549
- --------------------------------------------------------------------------------
Sierra Wireless, Inc. 1 22,400 500,640
- --------------------------------------------------------------------------------
Telular Corp. 1 68,100 757,953
- --------------------------------------------------------------------------------
UTStarcom, Inc. 1 28,800 758,880
-------------
9,017,846
- --------------------------------------------------------------------------------
COMPUTERS & PERIPHERALS--1.6%
Lexar Media, Inc. 1 70,200 652,860
- --------------------------------------------------------------------------------
Network Engines, Inc. 1 110,700 369,738
- --------------------------------------------------------------------------------
Novatel Wireless, Inc. 1 49,300 726,682
-------------
1,749,280
- --------------------------------------------------------------------------------
ELECTRONIC EQUIPMENT & INSTRUMENTS--4.5%
Aeroflex, Inc. 1 90,800 1,142,264
- --------------------------------------------------------------------------------
CellStar Corp. 1 65,600 457,232
- --------------------------------------------------------------------------------
FLIR Systems, Inc. 1 22,700 1,064,857
- --------------------------------------------------------------------------------
Merix Corp. 1 21,400 332,770
- --------------------------------------------------------------------------------
Plexus Corp. 1 39,500 568,010
- --------------------------------------------------------------------------------
Staktek Holdings, Inc. 1 35,900 323,100
- --------------------------------------------------------------------------------
TTM Technologies,
Inc. 1 34,700 385,517
- --------------------------------------------------------------------------------
Veeco Instruments,
Inc. 1 22,700 516,425
-------------
4,790,175
MARKET VALUE
SHARES SEE NOTE 1
- --------------------------------------------------------------------------------
INTERNET SOFTWARE & SERVICES--9.0%
Aladdin Knowledge
Systems Ltd. 1 51,200 $ 1,046,528
- --------------------------------------------------------------------------------
Ask Jeeves, Inc. 1 18,200 645,554
- --------------------------------------------------------------------------------
Blue Coat
Systems, Inc. 1 10,000 445,910
- --------------------------------------------------------------------------------
Digital River, Inc. 1 38,500 991,375
- --------------------------------------------------------------------------------
Digitas, Inc. 1 46,000 455,860
- --------------------------------------------------------------------------------
eCollege.com, Inc. 1 50,000 904,000
- --------------------------------------------------------------------------------
Ivillage, Inc. 1 81,700 522,880
- --------------------------------------------------------------------------------
National Information
Consortium, Inc. 1 178,300 928,943
- --------------------------------------------------------------------------------
Netease.com, Inc.,
ADR 1 10,500 430,710
- --------------------------------------------------------------------------------
SINA Corp. 1 30,900 880,650
- --------------------------------------------------------------------------------
SonicWALL, Inc. 1 70,500 504,780
- --------------------------------------------------------------------------------
SupportSoft, Inc. 1 111,000 1,097,790
- --------------------------------------------------------------------------------
VeriSign, Inc. 1 40,900 659,717
-------------
9,514,697
- --------------------------------------------------------------------------------
IT SERVICES--1.8%
Aquantive, Inc. 1 45,000 452,250
- --------------------------------------------------------------------------------
Cognizant Technology
Solutions Corp. 1 16,600 718,116
- --------------------------------------------------------------------------------
Intelligroup, Inc. 1 115,900 700,036
-------------
1,870,402
- --------------------------------------------------------------------------------
OFFICE ELECTRONICS--0.9%
Metrologic
Instruments, Inc. 1 61,600 968,352
- --------------------------------------------------------------------------------
SEMICONDUCTORS & SEMICONDUCTOR
EQUIPMENT--11.0%
AMIS Holdings, Inc. 1 37,400 539,345
- --------------------------------------------------------------------------------
Atheros
Communications, Inc. 1 35,800 505,854
- --------------------------------------------------------------------------------
ATI Technologies, Inc. 1 39,500 574,725
- --------------------------------------------------------------------------------
ATMI, Inc. 1 27,200 600,576
- --------------------------------------------------------------------------------
Diodes, Inc. 1 28,700 623,077
- --------------------------------------------------------------------------------
Exar Corp. 1 62,100 947,646
- --------------------------------------------------------------------------------
Integrated Device
Technology, Inc. 1 45,400 610,630
- --------------------------------------------------------------------------------
Integrated Silicon
Solution, Inc. 1 50,800 697,484
13 | OPPENHEIMER EMERGING GROWTH FUND
STATEMENT OF INVESTMENTS Unaudited / Continued
MARKET VALUE
SHARES SEE NOTE 1
- --------------------------------------------------------------------------------
SEMICONDUCTORS & SEMICONDUCTOR
EQUIPMENT Continued
LTX Corp. 1 41,700 $ 455,781
- --------------------------------------------------------------------------------
Microsemi Corp. 1 54,500 592,415
- --------------------------------------------------------------------------------
OmniVision
Technologies, Inc. 1 48,300 1,077,187
- --------------------------------------------------------------------------------
ON Semiconductor
Corp. 1 81,400 393,162
- --------------------------------------------------------------------------------
PLX Technology, Inc. 1 36,300 471,174
- --------------------------------------------------------------------------------
Silicon
Laboratories, Inc. 1 20,600 971,290
- --------------------------------------------------------------------------------
Skyworks
Solutions, Inc. 1 81,700 699,352
- --------------------------------------------------------------------------------
TranSwitch Corp. 1 244,400 393,484
- --------------------------------------------------------------------------------
Trident
Microsystems, Inc. 1 50,300 697,661
- --------------------------------------------------------------------------------
TriQuint
Semiconductor, Inc. 1 70,000 384,300
- --------------------------------------------------------------------------------
Vitesse
Semiconductor Corp. 1 95,900 410,452
-------------
11,645,595
- --------------------------------------------------------------------------------
SOFTWARE--6.9%
Activision, Inc. 1 113,900 1,715,334
- --------------------------------------------------------------------------------
Altiris, Inc. 1 31,200 789,360
- --------------------------------------------------------------------------------
Captiva Software
Corp. 1 36,300 391,677
- --------------------------------------------------------------------------------
FileNet Corp. 1 24,100 661,786
- --------------------------------------------------------------------------------
InterVoice-Brite, Inc. 1 70,000 871,500
- --------------------------------------------------------------------------------
Macromedia, Inc. 1 37,600 774,560
- --------------------------------------------------------------------------------
Magma Design
Automation, Inc. 1 49,800 928,272
- --------------------------------------------------------------------------------
ScanSoft, Inc. 1 109,000 529,740
- --------------------------------------------------------------------------------
Sonic Solutions, Inc. 1 37,600 677,176
-------------
7,339,405
- --------------------------------------------------------------------------------
MATERIALS--0.4%
- --------------------------------------------------------------------------------
METALS & MINING--0.4%
GrafTech
International Ltd. 1 50,900 451,483
-------------
Total Common Stocks
(Cost $104,924,775) 109,142,641
MARKET VALUE
UNITS SEE NOTE 1
- --------------------------------------------------------------------------------
RIGHTS, WARRANTS AND CERTIFICATES--0.0%
- --------------------------------------------------------------------------------
Discovery Laboratories,
Inc. Wts., Exp. 9/20/10 1,2
(Cost $0) 6,800 $ 53,900
PRINCIPAL
AMOUNT
- --------------------------------------------------------------------------------
JOINT REPURCHASE AGREEMENTS--3.6%
- --------------------------------------------------------------------------------
Undivided interest of 0.69% in joint
repurchase agreement (Principal
Amount/Market Value $554,815,000,
with a maturity value of $554,860,310)
with PaineWebber, Inc., 0.98%, dated
4/30/04, to be repurchased at
$3,801,310 on 5/3/04, collateralized
by Federal National Mortgage Assn.,
5.50%--6.50%, 7/1/32--11/1/33, with
a value of $566,733,053
(Cost $3,801,000) $3,801,000 3,801,000
- --------------------------------------------------------------------------------
TOTAL INVESTMENTS,
AT VALUE
(COST $108,725,775) 106.4% 112,997,541
- --------------------------------------------------------------------------------
LIABILITIES
IN EXCESS OF
OTHER ASSETS (6.4) (6,839,856)
----------------------------------
NET ASSETS 100.0% $106,157,685
==================================
FOOTNOTES TO STATEMENT OF INVESTMENTS
1. Non-income producing security.
2. Identifies issues considered to be illiquid or restricted. See Note 5 of
Notes to Financial Statements.
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
14 | OPPENHEIMER EMERGING GROWTH FUND
STATEMENT OF ASSETS AND LIABILITIES Unaudited
April 30, 2004
- --------------------------------------------------------------------------------
ASSETS
- --------------------------------------------------------------------------------
Investments, at value (cost $108,725,775)--see accompanying
statement of investments $112,997,541
- --------------------------------------------------------------------------------
Cash 169,678
- --------------------------------------------------------------------------------
Receivables and other assets:
Investments sold 831,353
Shares of beneficial interest sold 470,414
Interest and dividends 9,281
Other 4,478
-------------
Total assets 114,482,745
- --------------------------------------------------------------------------------
LIABILITIES
- --------------------------------------------------------------------------------
Payables and other liabilities:
Investments purchased 4,672,137
Shares of beneficial interest redeemed 3,575,710
Distribution and service plan fees 23,226
Transfer and shareholder servicing agent fees 21,148
Shareholder communications 14,504
Trustees' compensation 2,976
Other 15,359
-------------
Total liabilities 8,325,060
- --------------------------------------------------------------------------------
NET ASSETS $106,157,685
=============
- --------------------------------------------------------------------------------
COMPOSITION OF NET ASSETS
- --------------------------------------------------------------------------------
Paid-in capital $106,198,610
- --------------------------------------------------------------------------------
Accumulated net investment loss (1,011,927)
- --------------------------------------------------------------------------------
Accumulated net realized loss on investments (3,300,764)
- --------------------------------------------------------------------------------
Net unrealized appreciation on investments 4,271,766
-------------
NET ASSETS $106,157,685
=============
15 | OPPENHEIMER EMERGING GROWTH FUND
STATEMENT OF ASSETS AND LIABILITIES Unaudited / Continued
- --------------------------------------------------------------------------------
NET ASSET VALUE PER SHARE
- --------------------------------------------------------------------------------
Class A Shares:
Net asset value and redemption price per share
(based on net assets of $60,926,256 and
6,483,158 shares of beneficial interest outstanding) $9.40
Maximum offering price per share (net asset value
plus sales charge of 5.75% of offering price) $9.97
- --------------------------------------------------------------------------------
Class B Shares:
Net asset value, redemption price (excludes applicable
contingent deferred sales charge) and offering price per
share (based on net assets of $22,606,370 and 2,476,197
shares of beneficial interest outstanding) $9.13
- --------------------------------------------------------------------------------
Class C Shares:
Net asset value, redemption price (excludes applicable
contingent deferred sales charge) and offering price per
share (based on net assets of $16,370,186 and 1,790,918
shares of beneficial interest outstanding) $9.14
- --------------------------------------------------------------------------------
Class N Shares:
Net asset value, redemption price (excludes applicable
contingent deferred sales charge) and offering price per
share (based on net assets of $2,988,912 and 321,518 shares
of beneficial interest outstanding) $9.30
- --------------------------------------------------------------------------------
Class Y Shares:
Net asset value, redemption price and offering price
per share (based on net assets of $3,265,961 and 342,306
shares of beneficial interest outstanding) $9.54
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
16 | OPPENHEIMER EMERGING GROWTH FUND
STATEMENT OF OPERATIONS Unaudited
For the Six Months Ended April 30, 2004
- --------------------------------------------------------------------------------
INVESTMENT INCOME
- --------------------------------------------------------------------------------
Dividends $ 41,372
- --------------------------------------------------------------------------------
Interest 11,246
---------------
Total investment income 52,618
- --------------------------------------------------------------------------------
EXPENSES
- --------------------------------------------------------------------------------
Management fees 559,725
- --------------------------------------------------------------------------------
Distribution and service plan fees:
Class A 79,261
Class B 115,337
Class C 81,635
Class N 7,312
- --------------------------------------------------------------------------------
Transfer and shareholder servicing agent fees:
Class A 87,210
Class B 50,307
Class C 29,272
Class N 5,911
Class Y 57
- --------------------------------------------------------------------------------
Shareholder communications:
Class A 12,216
Class B 8,440
Class C 3,595
Class N 682
- --------------------------------------------------------------------------------
Custodian fees and expenses 16,585
- --------------------------------------------------------------------------------
Trustees' compensation 2,186
- --------------------------------------------------------------------------------
Other 15,677
---------------
Total expenses 1,075,408
Less reduction to custodian expenses (631)
Less voluntary waiver of transfer and
shareholder servicing agent fees:
Class B (10,221)
Class C (1,121)
Class N (581)
Class Y (4)
---------------
Net expenses 1,062,850
- --------------------------------------------------------------------------------
NET INVESTMENT LOSS (1,010,232)
- --------------------------------------------------------------------------------
REALIZED AND UNREALIZED GAIN (LOSS)
- --------------------------------------------------------------------------------
Net realized gain on investments 6,307,629
- --------------------------------------------------------------------------------
Net change in unrealized appreciation on investments (16,654,313)
- --------------------------------------------------------------------------------
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS $(11,356,916)
===============
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
17 | OPPENHEIMER EMERGING GROWTH FUND
STATEMENTS OF CHANGES IN NET ASSETS
SIX MONTHS YEAR
ENDED ENDED
APRIL 30, 2004 OCTOBER 31,
(UNAUDITED) 2003
- ---------------------------------------------------------------------------
OPERATIONS
- ---------------------------------------------------------------------------
Net investment loss $ (1,010,232) $ (833,591)
- ---------------------------------------------------------------------------
Net realized gain 6,307,629 5,534,053
- ---------------------------------------------------------------------------
Net change in unrealized appreciation
(depreciation) (16,654,313) 23,236,139
----------------------------
Net increase (decrease) in net assets
resulting from operations (11,356,916) 27,936,601
- ---------------------------------------------------------------------------
BENEFICIAL INTEREST TRANSACTIONS
- ---------------------------------------------------------------------------
Net increase in net assets resulting
from beneficial interest transactions:
Class A 7,928,689 23,540,294
Class B 4,477,238 8,157,568
Class C 4,371,056 5,135,955
Class N 872,494 1,182,442
Class Y 723,843 1,354,893
- ---------------------------------------------------------------------------
NET ASSETS
- ---------------------------------------------------------------------------
Total increase 7,016,404 67,307,753
- ---------------------------------------------------------------------------
Beginning of period 99,141,281 31,833,528
----------------------------
End of period (including accumulated
net investment loss of $1,011,927
and $1,695, respectively) $106,157,685 $99,141,281
============================
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
18 | OPPENHEIMER EMERGING GROWTH FUND
FINANCIAL HIGHLIGHTS
SIX MONTHS YEAR
ENDED ENDED
APRIL 30, 2004 OCT. 31,
Class A (UNAUDITED) 2003 2002 2001 1
- -------------------------------------------------------------------------------------------------------------------------
PER SHARE OPERATING DATA
- -------------------------------------------------------------------------------------------------------------------------
Net asset value, beginning of period $10.30 $ 5.84 $ 8.45 $10.00
- -------------------------------------------------------------------------------------------------------------------------
Income (loss) from investment operations:
Net investment loss (.08) (.08) (.10) (.03)
Net realized and unrealized gain (loss) (.82) 4.54 (2.51) (1.49)
-----------------------------------------
Total from investment operations (.90) 4.46 (2.61) (1.52)
- -------------------------------------------------------------------------------------------------------------------------
Dividends and/or distributions to shareholders:
Dividends from net investment income -- -- -- (.03)
- -------------------------------------------------------------------------------------------------------------------------
Net asset value, end of period $ 9.40 $10.30 $ 5.84 $ 8.45
=========================================
- -------------------------------------------------------------------------------------------------------------------------
TOTAL RETURN, AT NET ASSET VALUE 2 (8.74)% 76.37% (30.89)% (15.22)%
- -------------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------------
RATIOS/SUPPLEMENTAL DATA
- -------------------------------------------------------------------------------------------------------------------------
Net assets, end of period (in thousands) $60,926 $59,396 $19,310 $20,392
- -------------------------------------------------------------------------------------------------------------------------
Average net assets (in thousands) $66,472 $28,386 $24,497 $16,941
- -------------------------------------------------------------------------------------------------------------------------
Ratios to average net assets: 3
Net investment loss (1.51)% (1.48)% (1.35)% (0.57)%
Total expenses 1.60% 1.77% 1.85% 1.58%
Expenses after expense reimbursement or fee waiver and
reduction to custodian expenses N/A 4 1.72% 1.78% N/A 4
- -------------------------------------------------------------------------------------------------------------------------
Portfolio turnover rate 108% 204% 263% 214%
1. For the period from November 1, 2000 (commencement of operations) to October
31, 2001.
2. Assumes an investment on the business day before the first day of the fiscal
period, with all dividends and distributions reinvested in additional shares on
the reinvestment date, and redemption at the value calculated on the last
business day of the fiscal period. Sales charges are not reflected in the total
returns. Total returns are not annualized for periods of less than one full
year. Returns do not reflect the deduction of taxes that a shareholder would pay
on Fund distributions or the redemption of Fund shares.
3. Annualized for periods of less than one full year.
4. Reduction to custodian expenses less than 0.01%.
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
19 | OPPENHEIMER EMERGING GROWTH FUND
FINANCIAL HIGHLIGHTS Continued
SIX MONTHS YEAR
ENDED ENDED
APRIL 30, 2004 OCT. 31,
Class B (UNAUDITED) 2003 2002 2001 1
- --------------------------------------------------------------------------------------------------------------------------
PER SHARE OPERATING DATA
- --------------------------------------------------------------------------------------------------------------------------
Net asset value, beginning of period $10.05 $ 5.74 $ 8.38 $10.00
- --------------------------------------------------------------------------------------------------------------------------
Income (loss) from investment operations:
Net investment loss (.10) (.09) (.12) (.07)
Net realized and unrealized gain (loss) (.82) 4.40 (2.52) (1.52)
------------------------------------------
Total from investment operations (.92) 4.31 (2.64) (1.59)
- --------------------------------------------------------------------------------------------------------------------------
Dividends and/or distributions to shareholders:
Dividends from net investment income -- -- -- (.03)
- --------------------------------------------------------------------------------------------------------------------------
Net asset value, end of period $ 9.13 $10.05 $ 5.74 $ 8.38
==========================================
- --------------------------------------------------------------------------------------------------------------------------
TOTAL RETURN, AT NET ASSET VALUE 2 (9.16)% 75.09% (31.50)% (15.96)%
- --------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------
RATIOS/SUPPLEMENTAL DATA
- --------------------------------------------------------------------------------------------------------------------------
Net assets, end of period (in thousands) $22,606 $20,520 $6,395 $3,866
- --------------------------------------------------------------------------------------------------------------------------
Average net assets (in thousands) $23,204 $10,544 $6,979 $2,256
- --------------------------------------------------------------------------------------------------------------------------
Ratios to average net assets: 3
Net investment loss (2.39)% (2.20)% (2.22)% (1.78)%
Total expenses 2.57% 2.83% 2.74% 2.47%
Expenses after expense reimbursement or fee waiver and
reduction to custodian expenses 2.48% 2.44% 2.67% N/A 4
- --------------------------------------------------------------------------------------------------------------------------
Portfolio turnover rate 108% 204% 263% 214%
1. For the period from November 1, 2000 (commencement of operations) to October
31, 2001.
2. Assumes an investment on the business day before the first day of the fiscal
period, with all dividends and distributions reinvested in additional shares on
the reinvestment date, and redemption at the value calculated on the last
business day of the fiscal period. Sales charges are not reflected in the total
returns. Total returns are not annualized for periods of less than one full
year. Returns do not reflect the deduction of taxes that a shareholder would pay
on Fund distributions or the redemption of Fund shares.
3. Annualized for periods of less than one full year.
4. Reduction to custodian expenses less than 0.01%.
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
20 | OPPENHEIMER EMERGING GROWTH FUND
SIX MONTHS YEAR
ENDED ENDED
APRIL 30, 2004 OCT. 31,
Class C (UNAUDITED) 2003 2002 2001 1
- --------------------------------------------------------------------------------------------------------------------------
PER SHARE OPERATING DATA
- --------------------------------------------------------------------------------------------------------------------------
Net asset value, beginning of period $10.06 $ 5.75 $ 8.39 $10.00
- --------------------------------------------------------------------------------------------------------------------------
Income (loss) from investment operations:
Net investment loss (.10) (.11) (.08) (.04)
Net realized and unrealized gain (loss) (.82) 4.42 (2.56) (1.54)
------------------------------------------
Total from investment operations (.92) 4.31 (2.64) (1.58)
- --------------------------------------------------------------------------------------------------------------------------
Dividends and/or distributions to shareholders:
Dividends from net investment income -- -- -- (.03)
- --------------------------------------------------------------------------------------------------------------------------
Net asset value, end of period $ 9.14 $10.06 $ 5.75 $ 8.39
==========================================
- --------------------------------------------------------------------------------------------------------------------------
TOTAL RETURN, AT NET ASSET VALUE 2 (9.15)% 74.96% (31.47)% (15.88)%
- --------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------
RATIOS/SUPPLEMENTAL DATA
- --------------------------------------------------------------------------------------------------------------------------
Net assets, end of period (in thousands) $16,370 $13,887 $4,877 $2,356
- --------------------------------------------------------------------------------------------------------------------------
Average net assets (in thousands) $16,428 $ 6,649 $3,061 $1,022
- --------------------------------------------------------------------------------------------------------------------------
Ratios to average net assets: 3
Net investment loss (2.36)% (2.22)% (2.25)% (1.76)%
Total expenses 2.46% 2.65% 2.72% 2.46%
Expenses after expense reimbursement or fee waiver and
reduction to custodian expenses 2.45% 2.47% 2.65% N/A 4
- --------------------------------------------------------------------------------------------------------------------------
Portfolio turnover rate 108% 204% 263% 214%
1. For the period from November 1, 2000 (commencement of operations) to October
31, 2001.
2. Assumes an investment on the business day before the first day of the fiscal
period, with all dividends and distributions reinvested in additional shares on
the reinvestment date, and redemption at the value calculated on the last
business day of the fiscal period. Sales charges are not reflected in the total
returns. Total returns are not annualized for periods of less than one full
year. Returns do not reflect the deduction of taxes that a shareholder would pay
on Fund distributions or the redemption of Fund shares.
3. Annualized for periods of less than one full year.
4. Reduction to custodian expenses less than 0.01%.
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS
21 | OPPENHEIMER EMERGING GROWTH FUND
FINANCIAL HIGHLIGHTS Continued
SIX MONTHS YEAR
ENDED ENDED
APRIL 30, 2004 OCT. 31,
Class N (UNAUDITED) 2003 2002 2001 1
- ------------------------------------------------------------------------------------------------------------------------
PER SHARE OPERATING DATA
- ------------------------------------------------------------------------------------------------------------------------
Net asset value, beginning of period $10.21 $ 5.81 $ 8.43 $8.28
- ------------------------------------------------------------------------------------------------------------------------
Income (loss) from investment operations:
Net investment loss (.09) (.10) (.08) (.05)
Net realized and unrealized gain (loss) (.82) 4.50 (2.54) .20
----------------------------------------
Total from investment operations (.91) 4.40 (2.62) .15
- ------------------------------------------------------------------------------------------------------------------------
Dividends and/or distributions to shareholders:
Dividends from net investment income -- -- -- --
- ------------------------------------------------------------------------------------------------------------------------
Net asset value, end of period $ 9.30 $10.21 $ 5.81 $8.43
========================================
- ------------------------------------------------------------------------------------------------------------------------
TOTAL RETURN, AT NET ASSET VALUE 2 (8.91)% 75.73% (31.08)% 1.81%
- ------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------
RATIOS/SUPPLEMENTAL DATA
- ------------------------------------------------------------------------------------------------------------------------
Net assets, end of period (in thousands) $2,989 $2,425 $594 $34
- ------------------------------------------------------------------------------------------------------------------------
Average net assets (in thousands) $2,942 $1,125 $412 $16
- ------------------------------------------------------------------------------------------------------------------------
Ratios to average net assets: 3
Net investment loss (1.88)% (1.76)% (1.63)% (1.69)%
Total expenses 2.01% 2.14% 2.18% 2.03%
Expenses after expense reimbursement or fee waiver and
reduction to custodian expenses 1.97% 2.00% 2.11% N/A 4
- ------------------------------------------------------------------------------------------------------------------------
Portfolio turnover rate 108% 204% 263% 214%
1. For the period from March 1, 2001 (inception of offering) to October 31,
2001.
2. Assumes an investment on the business day before the first day of the fiscal
period, with all dividends and distributions reinvested in additional shares on
the reinvestment date, and redemption at the value calculated on the last
business day of the fiscal period. Sales charges are not reflected in the total
returns. Total returns are not annualized for periods of less than one full
year. Returns do not reflect the deduction of taxes that a shareholder would pay
on Fund distributions or the redemption of Fund shares.
3. Annualized for periods of less than one full year.
4. Reduction to custodian expenses less than 0.01%.
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
22 | OPPENHEIMER EMERGING GROWTH FUND
SIX MONTHS YEAR
ENDED ENDED
APRIL 30, 2004 OCT. 31,
Class Y (UNAUDITED) 2003 2002 2001 1
- ---------------------------------------------------------------------------------------------------------------------------
PER SHARE OPERATING DATA
- ---------------------------------------------------------------------------------------------------------------------------
Net asset value, beginning of period $10.43 $ 5.88 $ 8.47 $10.00
- ---------------------------------------------------------------------------------------------------------------------------
Income (loss) from investment operations:
Net investment income (loss) (.06) (.09) (.08) .02
Net realized and unrealized gain (loss) (.83) 4.64 (2.51) (1.51)
-------------------------------------------
Total from investment operations (.89) 4.55 (2.59) (1.49)
- ---------------------------------------------------------------------------------------------------------------------------
Dividends and/or distributions to shareholders:
Dividends from net investment income -- -- - (.04)
- ---------------------------------------------------------------------------------------------------------------------------
Net asset value, end of period $ 9.54 $10.43 $ 5.88 $ 8.47
===========================================
- ---------------------------------------------------------------------------------------------------------------------------
TOTAL RETURN, AT NET ASSET VALUE 2 (8.53)% 77.38% (30.58)% (14.99)%
- ---------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------
RATIOS/SUPPLEMENTAL DATA
- ---------------------------------------------------------------------------------------------------------------------------
Net assets, end of period (in thousands) $3,266 $2,913 $657 $232
- ---------------------------------------------------------------------------------------------------------------------------
Average net assets (in thousands) $3,460 $1,449 $532 $ 30
- ------------------------------------------------------------------------------------------------------------------------
Ratios to average net assets: 3
Net investment loss (0.96)% (0.92)% (0.84)% (0.97)%
Total expenses 1.06% 1.15% 1.48% 3.87%
Expenses after expense reimbursement or fee waiver and
reduction to custodian expenses N/A 4,5 N/A 4 1.29% 1.28%
- ---------------------------------------------------------------------------------------------------------------------------
Portfolio turnover rate 108% 204% 263% 214%
1. For the period from November 1, 2000 (commencement of operations) to October
31, 2001.
2. Assumes an investment on the business day before the first day of the fiscal
period, with all dividends and distributions reinvested in additional shares on
the reinvestment date, and redemption at the value calculated on the last
business day of the fiscal period. Sales charges are not reflected in the total
returns. Total returns are not annualized for periods of less than one full
year. Returns do not reflect the deduction of taxes that a shareholder would pay
on Fund distributions or the redemption of Fund shares.
3. Annualized for periods of less than one full year.
4. Reduction to custodian expenses less than 0.01%.
5. Voluntary waiver of transfer agent fees less than 0.01%.
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
23 | OPPENHEIMER EMERGING GROWTH FUND
NOTES TO FINANCIAL STATEMENTS Unaudited
- --------------------------------------------------------------------------------
1. SIGNIFICANT ACCOUNTING POLICIES
Oppenheimer Emerging Growth Fund (the Fund) is an open-end management
investment company registered under the Investment Company Act of 1940, as
amended. The Fund's investment objective is to seek capital appreciation. The
Fund's investment advisor is OppenheimerFunds, Inc. (the Manager).
The Fund offers Class A, Class B, Class C, Class N and Class Y shares. Class
A shares are sold at their offering price, which is normally net asset value
plus a front-end sales charge. Class B, Class C and Class N shares are sold
without a front-end sales charge but may be subject to a contingent deferred
sales charge (CDSC). Class N shares are sold only through retirement plans.
Retirement plans that offer Class N shares may impose charges on those
accounts. Class Y shares are sold to certain institutional investors without
either a front-end sales charge or a CDSC. All classes of shares have identical
rights and voting privileges with respect to the Fund in general and exclusive
voting rights on matters that affect that class alone. Earnings, net assets and
net asset value per share may differ by minor amounts due to each class having
its own expenses directly attributable to that class. Classes A, B, C and N
have separate distribution and/or service plans. No such plan has been adopted
for Class Y shares. Class B shares will automatically convert to Class A shares
six years after the date of purchase. The Fund assesses a 2% fee on the
proceeds of fund shares that are redeemed (either by selling or exchanging to
another Oppenheimer fund) within 30 days of their purchase. The fee, which is
retained by the Fund, is accounted for as an addition to paid-in capital.
The following is a summary of significant accounting policies consistently
followed by the Fund.
- --------------------------------------------------------------------------------
SECURITIES VALUATION. The Fund calculates the net asset value of its shares as
of the close of The New York Stock Exchange (the Exchange), normally 4:00 P.M.
Eastern time, on each day the Exchange is open for business. Securities listed
or traded on National Stock Exchanges or other domestic or foreign exchanges
are valued based on the last sale price of the security traded on that exchange
prior to the time when the Fund's assets are valued. Securities traded on
NASDAQ are valued based on the closing price provided by NASDAQ prior to the
time when the Fund's assets are valued. In the absence of a sale, the security
is valued at the last sale price on the prior trading day, if it is within the
spread of the closing bid and asked prices, and if not, at the closing bid
price. Securities may be valued primarily using dealer-supplied valuations or a
portfolio pricing service authorized by the Board of Trustees. Securities
(including restricted securities) for which market quotations are not readily
available are valued at their fair value. Foreign securities whose values have
been materially affected by what the Manager identifies as a significant event
occurring before the Fund's assets are valued but after the close of their
respective foreign exchanges will be fair valued. Fair value is determined in
good faith using consistently applied procedures under the supervision of the
Board of Trustees. Short-term "money market type" debt securities with
remaining maturities of sixty days or less are valued at amortized cost (which
approximates market value).
24 | OPPENHEIMER EMERGING GROWTH FUND
- --------------------------------------------------------------------------------
JOINT REPURCHASE AGREEMENTS. Pursuant to an Exemptive Order issued by the
Securities and Exchange Commission, the Fund, along with other affiliated funds
advised by the Manager, may transfer uninvested cash balances into joint
trading accounts on a daily basis. These balances are invested in one or more
repurchase agreements. Securities pledged as collateral for repurchase
agreements are held by a custodian bank until the agreements mature. Each
agreement requires that the market value of the collateral be sufficient to
cover payments of interest and principal. In the event of default by the other
party to the agreement, retention of the collateral may be subject to legal
proceedings.
- --------------------------------------------------------------------------------
ALLOCATION OF INCOME, EXPENSES, GAINS AND LOSSES. Income, expenses (other than
those attributable to a specific class), gains and losses are allocated on a
daily basis to each class of shares based upon the relative proportion of net
assets represented by such class. Operating expenses directly attributable to a
specific class are charged against the operations of that class.
- --------------------------------------------------------------------------------
FEDERAL TAXES. The Fund intends to comply with provisions of the Internal
Revenue Code applicable to regulated investment companies and to distribute
substantially all of its investment company taxable income, including any net
realized gain on investments not offset by capital loss carryforwards, if any,
to shareholders, therefore, no federal income or excise tax provision is
required.
Net investment income (loss) and net realized gain (loss) may differ for
financial statement and tax purposes. The character of dividends and
distributions made during the fiscal year from net investment income or net
realized gains may differ from their ultimate characterization for federal
income tax purposes. Also, due to timing of dividends and distributions, the
fiscal year in which amounts are distributed may differ from the fiscal year in
which the income or net realized gain was recorded by the Fund.
As of April 30, 2004, the Fund had available for federal income tax purposes
an estimated unused capital loss carryforward of $3,262,472 expiring by 2012.
This estimated capital loss carryforward represents carryforward as of the end
of the last fiscal year, increased for losses deferred under tax accounting
rules to the current fiscal year and is increased or decreased by capital
losses or gains realized in the first six months of the current fiscal year.
During the six months ended April 30, 2004 and the year ended October 31, 2003,
the Fund used $6,307,629 and $5,140,037, respectively, of carryforward to
offset capital gains realized.
As of October 31, 2003, the Fund had available for federal income tax purposes
an unused capital loss carryforward as follows:
EXPIRING
----------------------
2010 $9,570,101
25 | OPPENHEIMER EMERGING GROWTH FUND
NOTES TO FINANCIAL STATEMENTS Unaudited / Continued
- --------------------------------------------------------------------------------
1. SIGNIFICANT ACCOUNTING POLICIES Continued
TRUSTEES' COMPENSATION. The Fund has adopted an unfunded retirement plan for
the Fund's independent trustees. Benefits are based on years of service and
fees paid to each trustee during the years of service. During the six months
ended April 30, 2004, the Fund's projected benefit obligations were increased
by $550 and payments of $188 were made to retired trustees, resulting in an
accumulated liability of $2,056 as of April 30, 2004.
The Board of Trustees has adopted a deferred compensation plan for
independent trustees that enables trustees to elect to defer receipt of all or
a portion of the annual compensation they are entitled to receive from the
Fund. For purposes of determining the amount owed to the Trustee under the
plan, deferred amounts are treated as though equal dollar amounts had been
invested in shares of the Fund or in other Oppenheimer funds selected by the
Trustee. The Fund does purchase shares of the funds selected for deferral by
the Trustee in amounts equal to his or her deemed investment, resulting in a
Fund asset equal to the deferred compensation liability. Such assets are
included as a component of "Other" within the asset section of the Statement of
Assets and Liabilities. Deferral of trustees' fees under the plan will not
affect the net assets of the Fund, and will not materially affect the Fund's
assets, liabilities or net investment income per share. Amounts will be
deferred until distributed in accordance to the Plan.
- --------------------------------------------------------------------------------
DIVIDENDS AND DISTRIBUTIONS TO SHAREHOLDERS. Dividends and distributions to
shareholders, which are determined in accordance with income tax regulations,
are recorded on the ex-dividend date. Income and capital gain distributions, if
any, are declared and paid annually.
- --------------------------------------------------------------------------------
INVESTMENT INCOME. Dividend income is recorded on the ex-dividend date or upon
ex-dividend notification in the case of certain foreign dividends where the
ex-dividend date may have passed. Non-cash dividends included in dividend
income, if any, are recorded at the fair market value of the securities
received. Interest income, which includes accretion of discount and
amortization of premium, is accrued as earned.
- --------------------------------------------------------------------------------
EXPENSE OFFSET ARRANGEMENT. The reduction of custodian fees, if applicable,
represents earnings on cash balances maintained by the Fund.
- --------------------------------------------------------------------------------
SECURITY TRANSACTIONS. Security transactions are recorded on the trade date.
Realized gains and losses on securities sold are determined on the basis of
identified cost.
- --------------------------------------------------------------------------------
OTHER. The preparation of financial statements in conformity with U.S.
generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of income and expenses during the reporting
period. Actual results could differ from those estimates.
26 | OPPENHEIMER EMERGING GROWTH FUND
In the ordinary course of business, the Fund enters into contracts that
contain a variety of indemnifications. The Fund's maximum exposure under these
arrangements is unknown. However, the Fund has not had prior claims or losses
pursuant to these contracts and expects the risk of loss to be remote.
- --------------------------------------------------------------------------------
2. SHARES OF BENEFICIAL INTEREST
The Fund has authorized an unlimited number of no par value shares of
beneficial interest of each class. Transactions in shares of beneficial
interest were as follows:
SIX MONTHS ENDED APRIL 30, 2004 YEAR ENDED OCTOBER 31, 2003
SHARES AMOUNT SHARES AMOUNT
- ----------------------------------------------------------------------------
CLASS A
Sold 3,095,542 $ 32,446,140 6,075,182 $ 51,242,510
Redeemed (2,378,716) (24,517,451) (3,613,483) (27,702,216)
------------------------------------------------------------
Net increase 716,826 $ 7,928,689 2,461,699 $23,540,294
============================================================
- ----------------------------------------------------------------------------
CLASS B
Sold 899,751 $ 9,202,316 1,756,252 $ 14,456,517
Redeemed (465,312) (4,725,078) (828,442) (6,298,949)
------------------------------------------------------------
Net increase 434,439 $ 4,477,238 927,810 $ 8,157,568
============================================================
- ----------------------------------------------------------------------------
CLASS C
Sold 913,643 $ 9,338,456 1,820,923 $ 15,186,788
Redeemed (502,969) (4,967,400) (1,289,240) (10,050,833)
------------------------------------------------------------
Net increase 410,674 $ 4,371,056 531,683 $ 5,135,955
============================================================
- ----------------------------------------------------------------------------
CLASS N
Sold 143,247 $ 1,480,882 264,715 $ 2,110,308
Redeemed (59,255) (608,388) (129,515) (927,866)
------------------------------------------------------------
Net increase 83,992 $ 872,494 135,200 $ 1,182,442
============================================================
- ----------------------------------------------------------------------------
CLASS Y
Sold 156,360 $ 1,690,666 274,183 $ 2,217,398
Redeemed (93,396) (966,823) (106,636) (862,505)
------------------------------------------------------------
Net increase 62,964 $ 723,843 167,547 $ 1,354,893
============================================================
- --------------------------------------------------------------------------------
3. PURCHASES AND SALES OF SECURITIES
The aggregate cost of purchases and proceeds from sales of securities, other
than short-term obligations, for the six months ended April 30, 2004, were
$142,913,848 and $121,331,304, respectively.
27 | OPPENHEIMER EMERGING GROWTH FUND
NOTES TO FINANCIAL STATEMENTS Unaudited / Continued
- --------------------------------------------------------------------------------
4. FEES AND OTHER TRANSACTIONS WITH AFFILIATES
MANAGEMENT FEES. Management fees paid to the Manager were in accordance with
the investment advisory agreement with the Fund. Effective January 1, 2004, the
agreement provides for a fee at an annual rate of 1.00% of the first $200
million of average net assets, 0.95% of the next $200 million, 0.90% of the
next $200 million, and 0.85% of average annual net assets over $600 million.
Prior to January 1, 2004, the Fund pays the Manager an advisory fee at an
annual rate with slightly different breakpoints, as follows: 1.00% of the first
$500 million of average annual net assets, 0.90% of the next $500 million and
0.85% of average annual net assets over $1 billion.
- --------------------------------------------------------------------------------
TRANSFER AGENT FEES. OppenheimerFunds Services (OFS), a division of the
Manager, acts as the transfer and shareholder servicing agent for the Fund. The
Fund pays OFS a per account fee. For the six months ended April 30, 2004, the
Fund paid $160,803 to OFS for services to the Fund.
Additionally, Class Y shares are subject to minimum fees of $10,000 for
assets of $10 million or more. The Class Y shares are subject to the minimum
fees in the event that the per account fee does not equal or exceed the
applicable minimum fees. OFS may voluntarily waive the minimum fees.
OFS has voluntarily agreed to limit transfer and shareholder servicing agent
fees for all classes to 0.35% of average annual net assets per class. This
undertaking may be amended or withdrawn at any time.
- --------------------------------------------------------------------------------
DISTRIBUTION AND SERVICE PLAN (12B-1) FEES. Under its General Distributor's
Agreement with the Fund, OppenheimerFunds Distributor, Inc. (the Distributor)
acts as the Fund's principal underwriter in the continuous public offering of
the Fund's classes of shares.
- --------------------------------------------------------------------------------
SERVICE PLAN FOR CLASS A SHARES. The Fund has adopted a Service Plan for Class
A shares. It reimburses the Distributor for a portion of its costs incurred for
services provided to accounts that hold Class A shares. Reimbursement is made
quarterly at an annual rate of up to 0.25% of the average annual net assets of
Class A shares of the Fund. The Distributor currently uses all of those fees to
pay dealers, brokers, banks and other financial institutions quarterly for
providing personal services and maintenance of accounts of their customers that
hold Class A shares. Any unreimbursed expenses the Distributor incurs with
respect to Class A shares in any fiscal year cannot be recovered in subsequent
years. Fees incurred by the Fund under the Plan are detailed in the Statement
of Operations.
- -------------------------------------------------------------------------------
DISTRIBUTION AND SERVICE PLANS FOR CLASS B, CLASS C AND CLASS N SHARES. The
Fund has adopted Distribution and Service Plans for Class B, Class C and Class
N shares to compensate the Distributor for its services in connection with the
distribution of those shares and servicing accounts. Under the plans, the Fund
pays the Distributor an annual asset-based sales charge of 0.75% per year on
Class B shares and on Class C shares and 0.25% per year on Class N shares. The
Distributor also receives a service fee of up to 0.25% per year under each
plan. If either the Class B, Class C or Class N plan is terminated by the Fund
or by the shareholders of a class, the Board of Trustees and its independent
28 | OPPENHEIMER EMERGING GROWTH FUND
trustees must determine whether the Distributor shall be entitled to payment
from the Fund of all or a portion of the service fee and/or asset-based sales
charge in respect to shares sold prior to the effective date of such
termination. The Distributor's aggregate uncompensated expenses under the plan
at April 30, 2004 for Class B, Class C and Class N shares were $406,701,
$221,346 and $29,662, respectively. Fees incurred by the Fund under the plans
are detailed in the Statement of Operations.
- --------------------------------------------------------------------------------
SALES CHARGES. Front-end sales charges and contingent deferred sales charges
(CDSC) do not represent expenses of the Fund. They are deducted from the
proceeds of sales of Fund shares prior to investment or from redemption
proceeds prior to remittance, as applicable. The sales charges retained by the
Distributor from the sale of shares and the CDSC retained by the Distributor on
the redemption of shares is shown in the table below for the period indicated.
CLASS A CLASS B CLASS C CLASS N
CLASS A CONTINGENT CONTINGENT CONTINGENT CONTINGENT
FRONT-END DEFERRED DEFERRED DEFERRED DEFERRED
SALES CHARGES SALES CHARGES SALES CHARGES SALES CHARGES SALES CHARGES
SIX MONTHS RETAINED BY RETAINED BY RETAINED BY RETAINED BY RETAINED BY
ENDED DISTRIBUTOR DISTRIBUTOR DISTRIBUTOR DISTRIBUTOR DISTRIBUTOR
- ---------------------------------------------------------------------------------------------------------------------------
April 30, 2004 $103,292 $-- $24,575 $3,848 $835
- --------------------------------------------------------------------------------
5. ILLIQUID OR RESTRICTED SECURITIES
As of April 30, 2004, investments in securities included issues that are
illiquid or restricted. Restricted securities are purchased in private
placement transactions, are not registered under the Securities Act of 1933,
may have contractual restrictions on resale, and are valued under methods
approved by the Board of Trustees as reflecting fair value. A security may also
be considered illiquid if it lacks a readily available market or if its
valuation has not changed for a certain period of time. The Fund intends to
invest no more than 15% of its net assets (determined at the time of purchase
and reviewed periodically) in illiquid or restricted securities. Certain
restricted securities, eligible for resale to qualified institutional
investors, are not subject to that limitation. The aggregate value of illiquid
or restricted securities subject to this limitation as of April 30, 2004 was
$1,402,565, which represents 1.32% of the Fund's net assets, all of which are
considered restricted. Information concerning restricted securities is as
follows:
UNREALIZED
ACQUISITION VALUATION AS OF APPRECIATION
SECURITY DATES COST APRIL 30, 2004 (DEPRECIATION)
- ---------------------------------------------------------------------------------------------------------------------------
STOCKS AND/OR WARRANTS
Bio-Imaging Technologies, Inc. 9/12/03 $688,450 $574,908 $(113,542)
Discovery Laboratories, Inc. Wts.,
Exp. 9/20/10 6/18/03 -- 53,900 53,900
DOV Pharmaceutical, Inc. 3/15/04 778,312 773,757 (4,555)
29 | OPPENHEIMER EMERGING GROWTH FUND
NOTES TO FINANCIAL STATEMENTS Unaudited / Continued
- --------------------------------------------------------------------------------
6. BORROWING AND LENDING ARRANGEMENTS
The Fund entered into an "interfund borrowing and lending arrangement" with
other funds in the Oppenheimer funds complex, to allow funds to borrow for
liquidity purposes. The arrangement was initiated pursuant to exemptive relief
granted by the Securities and Exchange Commission (the SEC) to allow these
affiliated funds to lend money to, and borrow money from, each other, in an
attempt to reduce borrowing costs below those of bank loan facilities. The
SEC's order requires the Fund's Board of Trustees to adopt operating policies
and procedures to administer interfund borrowing and lending. Under the
arrangement the Fund may lend money to other Oppenheimer funds and may borrow
from other Oppenheimer funds at a rate set by the Fund's Board of Trustees,
based upon a recommendation by the Manager. The Fund's borrowings, if any, are
subject to asset coverage requirements under the Investment Company Act and the
provisions of the SEC order and other applicable regulations. If the Fund
borrows money, there is a risk that the loan could be called on one day's
notice, in which case the Fund might have to borrow from a bank at higher rates
if a loan were not available from another Oppenheimer fund. If the Fund lends
money to another fund, it will be subject to the risk that the other fund might
not repay the loan in a timely manner, or at all.
The Fund had no interfund borrowings or loans outstanding during the six
months ended or at April 30, 2004.
- --------------------------------------------------------------------------------
PORTFOLIO PROXY VOTING
POLICIES AND PROCEDURES Unaudited
- --------------------------------------------------------------------------------
The Fund has adopted Portfolio Proxy Voting Policies and Procedures under which
the Fund votes proxies relating to securities ("portfolio proxies") held by the
Fund. A description of the Fund's Portfolio Proxy Voting Policies and
Procedures is available (i) without charge, upon request, by calling the Fund
toll-free at 1.800.225.5677, (ii) on the Fund's website at
www.oppenheimerfunds.com, and (iii) on the SEC's website at www.sec.gov. In
addition, the Fund will be required to file new Form N-PX, with its complete
proxy voting record for the 12 months ended June 30th, no later than August
31st of each year. The first such filing is due no later than August 31, 2004,
for the twelve months ended June 30, 2004. Once filed, the Fund's Form N-PX
filing will be available (i) without charge, upon request, by calling the Fund
toll-free at 1.800.225.5677, and (ii) on the SEC's website at www.sec.gov.
30 | OPPENHEIMER EMERGING GROWTH FUND
Item 2. Code of Ethics
The registrant has adopted a code of ethics that applies to the
registrant's principal executive officer, principal financial officer, principal
accounting officer or controller or persons performing similar functions.
Item 3. Audit Committee Financial Expert
The Board of Trustees of the registrant has determined that the
registrant does not have an audit committee financial expert serving on its
Audit Committee. In this regard, no member of the Audit Committee was identified
as having all of the technical attributes identified in Instruction 2(b) to Item
3 of Form N-CSR to qualify as an "audit committee financial expert," whether
through the type of specialized education or experience described in that
Instruction. The Board has concluded that while the members of the Audit
Committee collectively have the necessary attributes and experience required to
serve effectively as an Audit Committee, no single member possesses all of the
required technical attributes through the particular methods of education or
experience set forth in the Instructions to be designated as an audit committee
financial expert.
Item 4. Principal Accountant Fees and Services
Not applicable to semiannual reports.
Item 5. Not applicable
Item 6. Schedule of Investments
Not applicable
Item 7. Not applicable
Item 8. Not applicable
Item 9. Submission of Matters to a Vote of Security Holders
The Board is responsible for approving nominees for election as
trustees. To assist in this task, the Board has designated the Audit Committee
as the nominating committee for the Board. It reviews and recommends nominees to
the Board. The Committee is comprised entirely of disinterested trustees as
defined in Section 2(a)(19) of the Investment Company Act of 1940.
The Audit Committee charter describes the responsibilities of the
Committee in nominating candidates for election as independent Trustees of the
Registrant. The Registrant's Board has adopted a written charter for the
Committee. A current copy of the Audit Committee charter is available to
shareholders on the OppenheimerFunds website at www.oppenheimerfunds.com.
Under the current policy, if the Board determines that a vacancy
exists or is likely to exist on the Board, the Audit Committee of the Board will
consider candidates for Board membership including recommended by Registrant
shareholders. The Audit Committee will consider nominees recommended by
independent Board members or recommended by any other Board members including
Board members affiliated with the Registrant's investment advisors. The
Committee may, upon Board approval, retain an executive search firm to assist in
screening potential candidates. Upon Board approval, the Audit Committee may
also use the services of legal, financial, or other external counsel that it
deems necessary or desirable in the screening process. Shareholders wishing to
submit a nominee for election to the Board may do so by mailing their submission
to the offices of OppenheimerFunds, Inc., 6803 South Tucson Way, Centennial, CO
80112, to the attention of the Board of Trustees of the named Registrant, c/o
the Secretary of the Registrant.
The Committee's process for identifying and evaluating nominees for
trustees includes a number of factors. In screening candidates for board
membership, whether the candidate is suggested by Board members, shareholders or
others, the Committee considers the candidate's professional experience,
soundness of judgment, integrity, ability to make independent, analytical
inquiries, collegiality, willingness and ability to devote the time required to
perform Board activities adequately, ability to represent the interests of all
shareholders of the Registrant, and diversity relative to the board's
composition. Candidates are expected to provide a mix of attributes, experience,
perspective and skills necessary to effectively advance the interests of
shareholders.
Item 10. Controls and Procedures
(a) Based on their evaluation of registrant's disclosure controls and
procedures (as defined in rule 30a-2(c) under the Investment
Company Act of 1940 (17 CFR 270.30a-2(c)) as of April 30, 2004,
registrant's principal executive officer and principal financial
officer found registrant's disclosure controls and procedures to
provide reasonable assurances that information required to be
disclosed by registrant in the reports that it files under the
Securities Exchange Act of 1934 (a) is accumulated and
communicated to registrant's management, including its principal
executive officer and principal financial officer, to allow timely
decisions regarding required disclosure, and (b) is recorded,
processed, summarized and reported, within the time periods
specified in the rules and forms adopted by the U.S. Securities
and Exchange Commission.
(b) There have been no significant changes in registrant's internal
controls over financial reporting that occurred during the
registrant's last fiscal half-year that has materially affected,
or is reasonably likely to materially affect, the registrant's
internal control over financial reporting.
Item 11. Exhibits.
(a) Exhibit attached hereto. (Attach code of ethics as exhibit)
(b) Exhibits attached hereto. (Attach certifications as exhibits)